Aimfinity Investment CORP I DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Aimfinity Investment Corp. I issued a Form 8-K to clarify redemption procedures for its upcoming Extraordinary General Meeting, addressing shareholder inquiries regarding the Docter Business Combination.
Aimfinity Investment Corp. I seeks shareholder approval to extend its business combination deadline to July 28, 2026, and waive the net tangible asset requirement to facilitate the Docter Inc. merger.
Aimfinity Investment Corp. I is seeking shareholder approval for a business combination with Docter Inc., a health monitoring technology company, in a deal valued at $60 million.
DEFA14A: Aimfinity Investment Corp. I Revises Trust Account Contribution for Charter Amendment Proposal
Aimfinity Investment Corp. I announces revisions to the terms and conditions of its Charter Amendment Proposal, including an adjustment to the required contribution to the trust account for each monthly extension.
Aimfinity Investment Corp. I has adjourned its extraordinary general meeting to January 9, 2024, and extended the deadline for shareholders to deliver redemption requests to January 8, 2025.
Aimfinity Investment Corp. I is requesting shareholder approval to amend its charter, extending the deadline to complete a business combination and allowing for further extensions.
Aimfinity Investment Corp. I is asking shareholders to approve a charter amendment to extend the deadline for completing a business combination from April 28, 2024, to January 28, 2025, providing more time to finalize the Docter Inc. merger.